CINP 2026 photo gallery is now online It has already been a few weeks since the CINP community came together in Glasgow for four memorable days of science, exchange, collaboration and connection. The official CINP 2026 Photo Gallery is now online, capturing many of the people and moments that made the congress so special – from scientific sessions and lively discussions to reunions, new connections and shared celebrations. We invite you to browse the gallery, find yourself and your colleagues, and revisit some of your favourite memories from Glasgow. And if you were not able to join us this time, we hope the photographs offer a glimpse of the CINP community – and perhaps some inspiration to be part of the next CINP Congress. |
If you were unable to attend our recent webinar, the recording is now available to watch on the CINP website and YouTube channel. "Psilocybin in Depression: Insights From Contemporary Clinical Trials" features Dr. Joshua D. Rosenblat and Dr. Danica Johnson (University of Toronto & University Health Network, Canada), who provide a comprehensive overview of the latest clinical trial evidence on psilocybin for depression. The webinar explores current findings on efficacy and safety, the regulatory and ethical frameworks underpinning clinical research, and the emerging challenges and opportunities that continue to shape this field. Watch the recording at your convenience and stay up to date with developments in neuropsychopharmacology. |
We're delighted to share that the International Journal of Neuropsychopharmacology has achieved an increased Impact Factor in the latest Journal Citation Reports release. This growth reflects more than citations alone: readership, article usage, and engagement across the neuropsychopharmacology community demonstrate that research published in IJNP is being discovered, read, and used by scientists around the world. We are particularly proud that our Impact Factor remains very close to the metric calculated without journal self-citations, highlighting that IJNP's influence is driven by the broader research community and reflecting genuine reach, relevance, and scientific impact. We extend our congratulations to the past editorial board team for this achievement. Consider IJNP as the home for your next paper, and explore our Special Collections for opportunities to contribute to focused, high-impact areas of research. |
Professor Shigeto Yamawaki, former CINP President (2014–2016), passed away on June 8, 2026.
He made extraordinary contributions to neuropsychopharmacology, biological psychiatry, international scientific collaboration, and the development of CINP. His passing is a great loss not only to Japan and Asia but also to the worldwide neuropsychopharmacology community. We extend our heartfelt condolences to his family, friends, colleagues, and trainees. |
We are pleased to congratulate the newly elected officers and councillors, who will officially assume their roles during the CINP 2026 Congress.
We warmly congratulate all those elected and look forward to their leadership and contributions to the global CINP community in the years ahead. We would also like to sincerely thank all candidates who stood in this election for their commitment, engagement, and willingness to serve CINP and the field of neuropsychopharmacology. |
Follow CINP on Social Media Stay connected with the latest news, research highlights, events, and updates from CINP. Join our growing global community across social media: Facebook: X (Twitter): Instagram: LinkedIn: https://www.linkedin.com/company/international-college-of-neuropsychopharmacology/ YouTube: Follow us to stay informed, engage with the community, and be part of the conversation shaping the future of neuropsychopharmacology. |
GLOBAL
| International Journal of Neuropsychopharmacology
Impact Factor: 4.8 |
-
August 11, 2026 07:53
-
July 13, 2026 13:07
-
July 10, 2026 10:00
